Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 4
2012 7
2013 14
2014 21
2015 21
2016 35
2017 34
2018 24
2019 43
2020 45
2021 43
2022 37
2023 32
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Pancreatic Neuroendocrine Tumor G2"
Page 1
Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor.
Zhou Y, Liu S, Liu C, Yang J, Lin Q, Zheng S, Chen C, Zhou Q, Chen R. Zhou Y, et al. Int J Biol Sci. 2021 Aug 28;17(14):3760-3775. doi: 10.7150/ijbs.61717. eCollection 2021. Int J Biol Sci. 2021. PMID: 34671197 Free PMC article.
Aims: Using Single-cell RNA sequencing (scRNA-seq), we explored the spatiotemporal heterogeneity of pancreatic neuroendocrine tumors (pNETs) and the underlying mechanism for malignant progression. ...Finally, we developed a gene signature (PCSK1 and SMOC1) de …
Aims: Using Single-cell RNA sequencing (scRNA-seq), we explored the spatiotemporal heterogeneity of pancreatic neuroendocrine …
Chemotherapy in NEN: still has a role?
Espinosa-Olarte P, La Salvia A, Riesco-Martinez MC, Anton-Pascual B, Garcia-Carbonero R. Espinosa-Olarte P, et al. Rev Endocr Metab Disord. 2021 Sep;22(3):595-614. doi: 10.1007/s11154-021-09638-0. Epub 2021 Apr 11. Rev Endocr Metab Disord. 2021. PMID: 33843007 Free PMC article. Review.
Neuroendocrine neoplasms (NENs) comprise a broad spectrum of tumors with widely variable biological and clinical behavior. Primary tumor site, extent of disease, tumor differentiation and expression of so matostatin receptors, proliferation and growth …
Neuroendocrine neoplasms (NENs) comprise a broad spectrum of tumors with widely variable biological and clinical behavior. Pri …
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
Murakami M, Fujimori N, Nakata K, Nakamura M, Hashimoto S, Kurahara H, Nishihara K, Abe T, Hashigo S, Kugiyama N, Ozawa E, Okamoto K, Ishida Y, Okano K, Takaki R, Shimamatsu Y, Ito T, Miki M, Oza N, Yamaguchi D, Yamamoto H, Takedomi H, Kawabe K, Akashi T, Miyahara K, Ohuchida J, Ogura Y, Nakashima Y, Ueki T, Ishigami K, Umakoshi H, Ueda K, Oono T, Ogawa Y. Murakami M, et al. J Gastroenterol. 2023 Jun;58(6):586-597. doi: 10.1007/s00535-023-01987-8. Epub 2023 Apr 26. J Gastroenterol. 2023. PMID: 37099152
BACKGROUND: Pancreatic neuroendocrine neoplasms (PanNENs) are a heterogeneous group of tumors. ...We evaluated the clinical characteristics of 371 patients with localized non-functioning pancreatic neuroendocrine tumors (G1/G2). We also c …
BACKGROUND: Pancreatic neuroendocrine neoplasms (PanNENs) are a heterogeneous group of tumors. ...We evaluated the clin …
Pancreatic neuroendocrine tumors: Nosography, management and treatment.
Orditura M, Petrillo A, Ventriglia J, Diana A, Laterza MM, Fabozzi A, Savastano B, Franzese E, Conzo G, Santini L, Ciardiello F, De Vita F. Orditura M, et al. Int J Surg. 2016 Apr;28 Suppl 1:S156-62. doi: 10.1016/j.ijsu.2015.12.052. Epub 2015 Dec 18. Int J Surg. 2016. PMID: 26708853 Free article. Review.
Pancreatic neuroendocrine tumors (pNETs) represent about 7% of all NETs, 8.7% of gastroenteropancreatic NETs (GEP-NETs) and 1-2% of all pancreatic neoplasms. ...Approximately 90% of pNETs are silent and non-functional; therefore, most patients are diag …
Pancreatic neuroendocrine tumors (pNETs) represent about 7% of all NETs, 8.7% of gastroenteropancreatic NETs (GEP-NETs) …
Diagnostic Management of Gastroenteropancreatic Neuroendocrine Neoplasms: Technique Optimization and Tips and Tricks for Radiologists.
Pellegrino F, Granata V, Fusco R, Grassi F, Tafuto S, Perrucci L, Tralli G, Scaglione M. Pellegrino F, et al. Tomography. 2023 Jan 27;9(1):217-246. doi: 10.3390/tomography9010018. Tomography. 2023. PMID: 36828370 Free PMC article. Review.
Furthermore, they are primarily nonfunctioning, while, in the case of insulinomas, gastrinomas, glucagonomas, vipomas, and somatostatinomas, they produce hormones responsible for clinical syndromes. The GEP-NEN tumor grade and cell differentiation may result in different c …
Furthermore, they are primarily nonfunctioning, while, in the case of insulinomas, gastrinomas, glucagonomas, vipomas, and somatostatinomas, …
Prognostic role and predictors of lymph node involvement in pancreatic neuroendocrine tumors.
Ren SJ, Tan QQ, Cao D, Ke NW, Liu XB, Wang X. Ren SJ, et al. Eur J Radiol. 2023 May;162:110772. doi: 10.1016/j.ejrad.2023.110772. Epub 2023 Mar 15. Eur J Radiol. 2023. PMID: 36940547
PURPOSE: To define the prognostic role of lymph node involvement (LNI) in patients with pancreatic neuroendocrine tumors (PNETs) and identify predictors of LNI using a comprehensive multifactor analysis focusing on preoperative radiological feat …
PURPOSE: To define the prognostic role of lymph node involvement (LNI) in patients with pancreatic neuroendocrine tu …
Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data.
Boilève A, Faron M, Fodil-Cherif S, Bayle A, Lamartina L, Planchard D, Tselikas L, Kanaan C, Scoazec JY, Ducreux M, Italiano A, Baudin E, Hadoux J. Boilève A, et al. Eur J Cancer. 2023 Jun;186:122-132. doi: 10.1016/j.ejca.2023.03.024. Epub 2023 Mar 24. Eur J Cancer. 2023. PMID: 37062210
RESULTS: MPs were obtained in 114 out of 156 eligible patients, including 12% NET-G1, 42% NET-G2, 13% NET-G3 and 35% neuroendocrine carcinoma (NEC). Primary sites were lung/thymus (40%), pancreas (19%), gastro-intestinal (16%), head&neck (10%), unknown (10%) and …
RESULTS: MPs were obtained in 114 out of 156 eligible patients, including 12% NET-G1, 42% NET-G2, 13% NET-G3 and 35% neuroendocrine c …
Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.
Ohmoto A, Rokutan H, Yachida S. Ohmoto A, et al. Int J Mol Sci. 2017 Jan 13;18(1):143. doi: 10.3390/ijms18010143. Int J Mol Sci. 2017. PMID: 28098761 Free PMC article. Review.
Pancreatic neuroendocrine neoplasms (pNENs) are rare tumors accounting for only 1%-2% of all pancreatic tumors. pNENs are pathologically heterogeneous and are categorized into three groups (neuroendocrine tumor: NET G1, NET G2; and …
Pancreatic neuroendocrine neoplasms (pNENs) are rare tumors accounting for only 1%-2% of all pancreatic tumor …
Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms.
Mafficini A, Scarpa A. Mafficini A, et al. Endocr Rev. 2019 Apr 1;40(2):506-536. doi: 10.1210/er.2018-00160. Endocr Rev. 2019. PMID: 30657883 Free PMC article. Review.
There has been a rapid increase in data publication during the last 10 years, mainly driven by high-throughput studies on pancreatic and small intestinal neuroendocrine tumors (NETs). This review summarizes the present knowledge on genetic and epigenetic alte …
There has been a rapid increase in data publication during the last 10 years, mainly driven by high-throughput studies on pancreatic …
Lymph node metastases and recurrence in pancreatic neuroendocrine neoplasms.
Nießen A, Schimmack S, Lewosinska M, Hinz U, Bechtiger FA, Hackert T, Büchler MW, Strobel O. Nießen A, et al. Surgery. 2022 Dec;172(6):1791-1799. doi: 10.1016/j.surg.2022.08.020. Epub 2022 Sep 28. Surgery. 2022. PMID: 36180252
We aimed to determine the frequency and prognostic impact of lymph node involvement in pancreatic neuroendocrine neoplasms. ...CONCLUSION: The presence and extent of lymph node involvement has considerable prognostic impact in pancreatic neur …
We aimed to determine the frequency and prognostic impact of lymph node involvement in pancreatic neuroendocrine neopla …
305 results